Circulating microbial dysbiosis is associated with chronic liver disease including
nonalcoholic steatohepatitis and alcoholic liver disease. In this study, we evaluated whether …

Objective To characterise gut microbiome in patients with hepatocellular carcinoma (HCC)
and evaluate the potential of microbiome as non-invasive biomarkers for HCC. Design We …

Hepatocellular carcinoma (HCC) is a malignant tumor with high incidence in China, which is
mainly related to chronic hepatitis B (CHB) and liver cirrhosis (LC) caused by hepatitis B …

Background Hepatocellular carcinoma (HCC) is the third leading cause of cancer mortality
worldwide. Increasing evidence indicates a close relationship between HCC and the human …

Background Primary liver cancer has high mortality and morbidity worldwide. However, the
characteristic of gut microbiota profile and its correlation with inflammation status in liver …

Oral, gut, and tumor microbiota have been implicated as important regulators in the
carcinogenesis and progression of gastrointestinal malignancies. However, few studies …

Background The significance of the relationship between the microbiota and diseases is
increasingly being recognized. However, the characterization of tumor microbiome and their …

Microbiota is implicated in hepatocellular carcinoma (HCC). The spectrum of intratumoral
microbiota associated with HCC progression remains elusive. Fluorescence in situ …

Background: HCC is the leading cause of cancer in chronic liver disease. A growing body of
experimental mouse models supports the notion that gut-resident and liver-resident …

Background Assessment and characterization of human colon microbiota is now a major
research area in human diseases, including in patients with hepatitis B liver cirrhosis …